Related Experiment Videos
Summary
Chlorpropamide (Chl) caused agranulocytosis in an elderly patient. Chl-dependent antibodies inhibited white blood cell progenitor development, leading to low neutrophil counts.
Area of Science:
- Hematology
- Immunology
- Pharmacology
Background:
- Investigated the mechanism of isolated agranulocytosis and marrow pure white cell aplasia.
- Studied an elderly male patient receiving chlorpropamide (Chl) without other toxic exposures.
- Assessed the patient's bone marrow for abnormalities in white blood cell precursors.
Observation:
- Patient presented with severe neutropenia (WBC 1800/mm3, 2% neutrophils).
- Bone marrow showed an absence of granulocytic precursors, with normal erythroid and megakaryocyte precursors.
- Serum Chl levels were high during the acute phase and undetectable during convalescence.
Findings:
- Patient's acute phase serum demonstrated potent complement-mediated inhibition of autologous granulocyte progenitors (CFU-GM).
- This inhibition was selective for CFU-GM, with minimal impact on erythroid or multipotent progenitors.
- Convalescent phase serum showed no inhibition; however, adding Chl restored potent, dose-dependent inhibition of CFU-GM, dependent on IgG antibodies.
Implications:
- Results suggest Chl-dependent, antibody-mediated immune inhibition of granulopoiesis as the mechanism for agranulocytosis.
- Highlights the potential for drug-induced immune reactions affecting specific hematopoietic cell lineages.
- Underscores the importance of considering drug-induced immune hematotoxicity in unexplained cytopenias.